Forefront Analytics »

Achilles Therapeutics shares owned by Forefront Analytics

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Forefront Analytics from 13F filings

Historical chart of Forefront Analytics investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Forefront Analytics consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Forefront Analytics

Quarter filed Position value Share count Share price at filing
2023-09-30 $71k 78k 0.91
2023-06-30 $71k 75k 0.95
2023-03-31 $72k 76k 0.96
2022-12-31 $28k 31k 0.90
2022-09-30 $74k 32k 2.31

More positions owned by Forefront Analytics

Ishares Tr Esg Aw Msci Eafe (ESGD)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Mmentm (MTUM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Flexshares Tr Stox Gbl Esg Slt (ESGG)
Ishares Tr Glb Infrastr Etf (IGF)
Ishares Tr Core High Dv Etf (HDV)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Spdr Ser Tr Ftse Int Gvt Etf (WIP)
Vanguard Index Fds Real Estate Etf (VNQ)
First Tr Exchange-traded No Amer Energy (EMLP)
Vanguard World Extended Dur (EDV)
Vanguard Intl Equity Index F Glb Ex Us Etf (VNQI)

View all positions for Forefront Analytics

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Artal Group
Baker Bros. Advisors
Redmile Group
Point72 Asset Management
Citadel Advisors
Virtu Financial
Millennium Management
Bank of America Corporation
Two Sigma Securities
Brave Asset Management
Global Retirement Partners
Jpmorgan Chase & Co
Royal Bank of Canada

View all funds holding Achilles Therapeutics